136 related articles for article (PubMed ID: 12602079)
1. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
Stevens JW; O'Hagan A
Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty.
Al MJ; Van Hout BA
Health Econ; 2000 Oct; 9(7):599-609. PubMed ID: 11103926
[TBL] [Abstract][Full Text] [Related]
4. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Claxton K
J Health Econ; 1999 Jun; 18(3):341-64. PubMed ID: 10537899
[TBL] [Abstract][Full Text] [Related]
5. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
O'Hagan A; Stevens JW
Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
[TBL] [Abstract][Full Text] [Related]
6. [Bayesian approach for the cost-effectiveness evaluation of healthcare technologies].
Berchialla P; Gregori D; Brunello F; Veltri A; Petrinco M; Pagano E
Epidemiol Prev; 2009; 33(3):123-8. PubMed ID: 19776461
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes.
Briggs AH
Int J Technol Assess Health Care; 2001; 17(1):69-82. PubMed ID: 11329846
[TBL] [Abstract][Full Text] [Related]
8. The choice of sample size: a mixed Bayesian / frequentist approach.
Pezeshk H; Nematollahi N; Maroufy V; Gittins J
Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
[TBL] [Abstract][Full Text] [Related]
9. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
10. Bayesian assessment of sample size for clinical trials of cost-effectiveness.
O'Hagan A; Stevens JW
Med Decis Making; 2001; 21(3):219-30. PubMed ID: 11386629
[TBL] [Abstract][Full Text] [Related]
11. Should commercial-in-confidence data be used by decision makers when making assessments of cost-effectiveness?
Drummond M
Appl Health Econ Health Policy; 2002; 1(2):53-4. PubMed ID: 14619251
[No Abstract] [Full Text] [Related]
12. Bayesian methods in health technology assessment: a review.
Spiegelhalter DJ; Myles JP; Jones DR; Abrams KR
Health Technol Assess; 2000; 4(38):1-130. PubMed ID: 11134920
[TBL] [Abstract][Full Text] [Related]
13. A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.
Sarker SJ; Whitehead A; Khan I
Comput Methods Programs Biomed; 2013 Jun; 110(3):471-89. PubMed ID: 23399102
[TBL] [Abstract][Full Text] [Related]
14. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
[TBL] [Abstract][Full Text] [Related]
15. The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.
Skrepnek GH
Pharmacoeconomics; 2007; 25(8):649-64. PubMed ID: 17640107
[TBL] [Abstract][Full Text] [Related]
16. Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.
Hernández MA; Vázquez-Polo FJ; González-Torre FJ; Bas EM
Int J Technol Assess Health Care; 2009 Oct; 25(4):537-45. PubMed ID: 19845984
[TBL] [Abstract][Full Text] [Related]
17. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
Briggs AH; O'Brien BJ; Blackhouse G
Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
[TBL] [Abstract][Full Text] [Related]
18. Introduction to Bayesian reasoning.
Hornberger J
Int J Technol Assess Health Care; 2001; 17(1):9-16. PubMed ID: 11329848
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy.
Townsend J; Buxton M
Health Policy; 1997 Mar; 39(3):181-94. PubMed ID: 10165460
[TBL] [Abstract][Full Text] [Related]
20. Can Bayesian methods make data and analyses more relevant to decision makers? A perspective from Medicare.
Sheingold SH
Int J Technol Assess Health Care; 2001; 17(1):114-22. PubMed ID: 11329838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
